SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015050
Filing Date
2019-08-09
Accepted
2019-08-09 07:17:22
Documents
49
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_intecpharma.htm 10-Q 350443
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) AND RULE f10q0619ex31-1_intecpharma.htm EX-31.1 11705
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AND RULE f10q0619ex31-2_intecpharma.htm EX-31.2 11073
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 f10q0619ex32-1_intecpharma.htm EX-32.1 4313
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 f10q0619ex32-2_intecpharma.htm EX-32.2 4390
  Complete submission text file 0001213900-19-015050.txt   1995426

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ntec-20190630.xml EX-101.INS 291253
7 XBRL SCHEMA FILE ntec-20190630.xsd EX-101.SCH 37310
8 XBRL CALCULATION FILE ntec-20190630_cal.xml EX-101.CAL 45461
9 XBRL DEFINITION FILE ntec-20190630_def.xml EX-101.DEF 76199
10 XBRL LABEL FILE ntec-20190630_lab.xml EX-101.LAB 206538
11 XBRL PRESENTATION FILE ntec-20190630_pre.xml EX-101.PRE 145296
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37521 | Film No.: 191011296
SIC: 2834 Pharmaceutical Preparations